Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
Saved in:
| Title: | Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage. |
|---|---|
| Authors: | Poverennaya I; Department of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria., Murtazina A; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Li L; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Centre for Bone and Arthritis Research at the Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden., Maili L; Stowers Institute for Medical Research, Kansas City, MO, USA., Sourada L; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic., Montano-Gutierrez LF; Department of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria., Galimullina R; Department of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria., Steinschaden T; Department of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria., Kaiser M; Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic., Zikmund T; Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic., Goralija A; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic., Gao T; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Attina A; IRCM, Université de Montpellier, ICM, INSERM, Montpellier, France., Clara O; Aix-Marseille University, CNRS, UMR 7288, IBDM, Marseille, France., Bartenhagen C; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany., Erickson A; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.; Department of Molecular Biosciences, the Wenner-Gren Institute, Stockholm University, Stockholm, Sweden., Gershtein Y; Department of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria., Chen S; Stowers Institute for Medical Research, Kansas City, MO, USA., Polaskova K; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Sterba J; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Semasch B; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Anderson ER; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Prakash V; Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA., Vincent T; Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA.; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Arceo M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Kogner P; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Schlisio S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Kharchenko PV; Altos Labs, San Diego Institute of Science, San Diego, CA, USA., David A; IRCM, Université de Montpellier, ICM, INSERM, Montpellier, France.; IRMB-PPC, INM, CHU Montpellier, INSERM, Université de Montpellier, CNRS, Montpellier, France., Kaiser J; Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic., Fischer M; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany., Skoda J; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic., Trainor PA; Stowers Institute for Medical Research, Kansas City, MO, USA.; Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS, USA., Chagin AS; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Centre for Bone and Arthritis Research at the Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden. andrei.chagin@gu.se.; Science for Life Laboratory, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. andrei.chagin@gu.se., Adameyko I; Department of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria. igor.adameyko@meduniwien.ac.at.; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. igor.adameyko@meduniwien.ac.at. |
| Source: | Nature communications [Nat Commun] 2026 Mar 09; Vol. 17 (1). Date of Electronic Publication: 2026 Mar 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-026-70375-6 |
